Objective: Appetite-suppressant drug fenfluramine is implicated in primary pulmonary hypertension (PPH) but the molecular pathways that mediate this effect are unknown. A mouse model incriminates the serotonin 5-HT 2B receptor but contrasts with other models where this receptor has been shown to mediate pulmonary arterial relaxation via nitric oxide production. Methods: We analyzed the human 5-HT 2B gene in 10 patients with appetite-suppressant drug-associated PPH. Results: A mutation causing premature truncation of the protein product was found in one patient. The mutation was not found in 80 control subjects and no 5-HT 2B mutation was found in 18 PPH patients not associated with appetite-suppressants. Functional analysis of the transfected receptor expressed either transiently in COS cells or stably in CHO cells demonstrated that the mutated receptor fails to activate the second messenger inositol-phosphates cascade and subsequent intracellular calcium release, in spite of normal expression at the cell membrane. The mutated receptor had no constitutive activity, and produced no dominant negative effect on the wild-type receptor. Conclusion: Loss of serotonin 5-HT 2B receptor function may predispose to fenfluramine-associated PPH in man.
Introduction
Primary pulmonary hypertension (PPH; primary PH) is a syndrome of dyspnea, fatigue, chest pain, and syncope resulting from a pre-capillary increase in pulmonary vascular resistance leading to sustained elevation of pulmonary arterial pressure, right ventricular failure, and death. From a clinical standpoint, a diagnosis of PPH is made after exclusion of known causes of secondary PH [1] . The overall incidence of PPH is 1-2 cases per million people per year, and increases up to 1 in 10,000 after intake of appetitesuppressant drugs, mainly fenfluramines and aminorex [2, 3] . Heterozygous loss-of-function mutations in the gene encoding the Bone Morphogenetic Protein (BMP) Receptor type II (BMPR2 gene) [4, 5] result in PPH transmitted as an autosomal dominant trait with low penetrance, around 10-20%. Such hereditary mutations are found in 25-30% of apparently sporadic cases [6] . The molecular causes for the majority of PPH cases, and the causes for reduced penetrance in BMPR2 mutation carriers, are unknown, but some other genetic predisposition is likely.
Fenfluramine and its stereoisomer dexfenfluramine (collectively referred to as fenfluramines) are indirect serotonin (5-HT) agonists which act by releasing 5-HT from storage vesicles. Fenfluramines are furthermore rapidly de-ethylated in vivo to form norfenfluramines, which bind 5-HT 2B and 5-HT 2C receptors with high affinity and display direct agonist activity [7] . 5-HT 2B is expressed in endothelial and smooth muscle cells of porcine and human pulmonary arteries [8, 9] , and is strongly overexpressed in lungs of PPH patients [10] . The 5-HT 2B receptor is a 7-transmembrane domain, Gprotein-coupled receptor, which contains a PDZ binding motif that can directly activate the constitutive endothelial nitric oxide synthase (eNOS) [11] . 5-HT 2B coupling to Gq furthermore activates the inositol-phosphates (IP) second messenger cascade and calcium release [8] .
In the pig pulmonary artery, 5-HT 2B agonists produce a reversible, endothelium-dependent relaxation [9] . In contrast with this vasodilative effect, however, 5-HT 2B has recently been implicated in vascular proliferation and PH in mice exposed to chronic hypoxia and norfenfluramine, a model that shares features with PPH [10] . To sort out the net effect of 5-HT 2B function in man, we investigated the human 5-HT 2B receptor gene in 10 patients with fenfluramine-related PPH, and found a loss-of-function mutation in one.
Methods

Study patients
We studied 10 patients who developed pulmonary arterial hypertension and reported intake of fenfluramine or dexfenfluramine, alone or in combination with diethylpropion (amfepramone) or phentermine. A diagnosis of PPH was reached after careful exclusion of known causes of PAH according to current guidelines [1] . The 10 patients, nine females and one male of Western European descent, took appetite suppressants at recommended anorexic dose. Family history regarding PPH was unremarkable over three generations. The investigation conforms with the principles outlined in the Declaration of Helsinki.
Mutagenesis and 5-HT 2B constructs
The different constructs of the human wild-type 5-HT 2B and the natural carboxy-terminal domain mutant R393X were performed by PCR as described [12] using the following primers: forward primer containing BamH1 restriction site (underlined) used for untagged and Green Fluorescent Protein (GFP) fusion receptors: 5V -TCGAGGATCCACCA-TGGCTCTCTCTTACAGAGTG; forward primer containing BamH1 restriction site used for the fusion protein between 5-HT 2B amino-terminal domain and a FLAG epitope (DYKDDDDK): CGAGGATCC ACCATGGACTA-CAAGGACGACGATGACAAGGCTCTCTCTTACA-GAGTGTCT, reverse primer containing a Xba1 restriction site (underlined) for wt5-HT 2B : TCGATCTAGA CTAT-ACATAACTAACTTGCTCTTC, reverse primer TCGA-TCTAGA T T T C AT C AT C A G C C A A AT G C AT C C C -GAAATGT for mutant 5-HT 2B . Following sequencing of the constructs, the mutated reading frames were subcloned into the bicistronic expression vector pEFIN3 as previously described [13] for generation of stable cell lines. All constructs were verified by sequencing before transfection. Constructs encoding fusion proteins of enhanced GFP (EGFP, Packard, Emerald) linked to the carboxy-terminus of wt or mutant 5-HT 2B were generated by PCR. 5-HT 2B was amplified with a forward primer described above and a reverse primer replacing the TGA stop codon by a XhoI restriction site (5V -TCGACTCGAG TACATAACTAACT-TGCTCTTC-3V for wild-type 5-HT 2B and 5V -TCGA-CTCGAGGCCAAATGCATCCCGAAATGT-3V for mutated 5-HT 2B ). EGFP was amplified by a forward primer containing a XhoI restriction site, followed by a flexible triglycine linker replacing the ATG start codon (5V -TCGACTCGAG GGGGGAGGTGTGAGCAAGGGCGAGGAG-3V ) and a reverse primer containing a Xba1 restriction site after the stop codon (5V -TCGATCTAGA TTACTTGTACAGCTCGTCC-3V ). EGFP was then cloned in frame with the 5-HT 2B Cterminus using the XhoI restriction site, and the linker sequence LEGGG between the two coding regions. After checking the constructs by sequencing, the fusion proteins coding sequences were transferred into the bicistronic vector pEFIN3, using the BamH1 and Xba1 restriction sites.
Expression of mutant receptors in CHO-K1 cell lines
CHO-K1 cells were cultured using HAM's F12 medium supplemented with 10% fetal calf serum (Life Technologies, Merelbeke, Belgium), 100 units/ml penicillin and 100 Ag/ml streptomycin (Life Technologies). Cells were serum-starved 24 h before all functional assays. A plasmid encoding apoaequorin under control of the SRa promoter [14] was transfected into CHO-K1 cells, using Fugene 6 (Roche). Puromycin (100 Ag/ml, Calbiochem) selection of transfectants was initiated 2 days after transfection. Individual clones were isolated 3 weeks later, and the clone with strongest functional response (luminescence signal) to ionomycin A (100 nM) and ATP (10 AM) was selected. Constructs encoding wild-type or mutant 5-HT 2B in the pEFIN3 bicistronic vector were further transfected using Fugene 6 in this apoaequorin expressing cell line. Selection of transfected cells was made for 14 days with 400 Ag/ml G418 (Life Technologies), and the population of mixed cell clones expressing wild-type or mutant receptors was used for binding and functional studies. At the same time, mini anion exchange columns were prepared as follows. Dowex resin AG1X8 formate form (Biorad, cat no. 140 -1454) was weighed and mixed with distilled water (25% w/v). About 1.6 ml of this resin was added to each Poly Prep column (Biorad, cat no. 731 -1550). The columns were then washed one time with 5 ml of distilled water. The supernatant of each well was applied to the columns containing anion exchange resin and the columns were rinsed with 5 ml of distilled water. The GPI was eluted with 10 ml of 5 mM DiNatetraborate/60 mM Ammonium formate. The IPs mixture were then eluted with 0.1 M formic acid/1 M ammonium formate and collected into scintillation vials. Radioactivity was determined by adding 3.5 ml of scintillation cocktail and counted in Tricarb. Results were expressed as the ratio between the radioactivity collected in the IP fraction over the radioactivity recovered from the solubilised cellular membranes. The use of this ratio allows for greater homogeneity in the data, as it reduces variation from differences in cell numbers from individual wells. The normalized IP formation was determined as a percentage of IP formation ratio compared with that obtained with buffer alone and referred to as 100% [15] .
IP assay
FACS analysis
The cellular expression of wild-type 5-HT 2B -GFP and R393X-5-HT 2B -GFP was measured by flow cytometry using 10 Ag/ml of FITC-conjugated anti-FLAG M2 antibody (Sigma). FACS analysis was performed on a FACScan flow cytometer using the CellQuest software (Becton Dickinson). The percentage of positive cells or Mean Channel Fluores- cence (MCF) was used to compare the levels of receptor expression. We defined the non-specific fluorescence as the fluorescence of cells transfected with the vector only (0% of positive cells).
Confocal microscopy
For confocal studies in living cells, stable CHO-K1 cell lines expressing wild-type or mutant 5-HT 2B -GFP were seeded the day before the analysis on 22 mm round glass coverslips, and grown for 18 h in a CO 2 incubator. Cells were rinsed in DMEM/F12 (Life Technologies) and the coverslips were placed in a 1-ml chamber with 200 Al of culture medium. Experiments were performed at 37j on a temperature-controlled stage. Cells were observed on a MRC 1024 confocal microscope (Bio-Rad Laboratories, Hemel Hempstead, Hertfordshire, United Kingdom) fitted on an Axiovert 100 inverted microscope (Zeiss, Oberkochen, Germany) equipped with a Plan-Neofluark 40 x/1.3 oil immersion objective (Zeiss). The 488-nm excitation beam of an ArgonKrypton laser and a 522/32 nm band-pass emission filter were used for selective viewing of the green fluorochrome. Fields of interest (512 Â 512 pixels) were selected visually. The gray scale datasets generated were transferred to an Indyk workstation (Silicon Graphics, Mountain View, CA) running the ImageSpacek software (Molecular Dynamics, Sunnydale, CA). No labeling was observed on untransfected CHO-K1 (data not shown). Figures were prepared on a Power Mack (Apple, Cupertino, CA) running Freehandk (Macromedia, San Francisco, CA) and Illustratork (Adobe, San Francisco, CA) softwares.
Aequorin-based functional assay
The functional response to 5-HT (Sigma) and BW723C86 (Tocris), a selective 5-HT 2B agonist, was analyzed by measuring the luminescence of aequorin as described [16] . Cells were collected from plates with Ca 2 + and Mg 2 + -free PBS supplemented with 5 mM EDTA, pelleted for 2 min at 1000 Â g, resuspended in DMEM at a density of 5 Â 10 6 cells/ml and incubated for 2 h in the dark in the presence of 5 AM coelenterazine H (Molecular Probes, Eugene, OR). Cells were diluted 5-fold before use. Agonists in a volume of 50 Al DMEM were added to 50 Al of the cell suspension (50,000 cells) and luminescence was measured for 30 s in a EG and G Berthold (Perkin-Elmer, Oosterhout, Netherlands). Functional parameters were determined with the PRISM software (Graphpad Software) using nonlinear regression applied to a sigmoidal dose -response model.
Preparation of membrane extracts
CHO-K1 cells stably expressing wild type 5-HT 2B and R393X mutant were cultured to 90% cell confluence. The medium was removed and the cells were scraped from the plates in Ca + + and Mg + + -free Phosphate-buffered saline (PBS). The cells were then centrifuged for 3 min at 1500 g and the pellets were resuspended in buffer A (15 mM TrisHCl pH 7.5; 2 mM MgCl2; 0.3 mM EDTA; 1 mM EGTA) and homogenized in a glass homogenizer. The crude membrane fraction was collected by two consecutive centrifugation steps at 40,000 Â g for 25 min separated by a washing step in buffer A. The final pellet was resuspended in buffer B (7.5 mM Tris-HCl pH 7.5; 12.5 mM MgCl2; 0.3 mM EDTA; 1 mM EGTA; 250 mM sucrose) and flash frozen in liquid nitrogen. Protein concentration was determined by the Folin method. 
Binding assays
Results
Mutation analysis
We investigated whether mutations in the human 5-HT 2B gene could be implicated in the development of PPH after intake of anorexigens by sequencing the whole coding region of the 5-HT 2B gene in our cohort of 10 patients. We found a heterozygous mutation in one patient, a white Belgian female diagnosed with PPH at the age of 50 years, 5 years after her last uptake of anorexigens. She had used fenfluramine and diethylpropion at recommended anorexic doses for a cumulated time of nine months. The mutation consisted of a C to T transition resulting in the substitution of a stop codon in place of an arginine codon at position 393 of the predicted protein sequence (R393X). This mutation resulted in the truncation of most of the carboxy-terminal tail of the receptor, removing putative palmitoylation and phosphorylation sites as well as the PDZ binding motif [11] ( Fig. 1) . This mutation was not found in 160 control alleles. 5-HT 2B gene sequencing in 18 PPH or PAH patients with no reported history of appetite-suppressant intake revealed no further mutation. Sequencing of the whole coding sequence and intronexon junctions of BMPR2 [17] in the 10 patients detected no mutation.
R393X mutant is normally expressed at the plasma membrane and binds LSD with normal affinity
In order to investigate the function of this new mutation (R393X), plasmids encoding wt5-HT 2B , R393X mutant, and wt5-HT 2B or R393X fused to a Green Fluorescent protein (GFP) or FLAG epitope were transfected in CHO-K1 cells stably expressing the reporter protein apoaequorin. Mixed populations of transfected cells were used for testing surface expression, binding, and functional properties of the receptors.
The binding parameters (B max and K d ) of mixed cell populations expressing wt5-HT 2B or R393X mutant receptor were determined by a saturation binding assay, using LSD as tracer. No specific LSD binding was observed on control CHO cells transfected with the empty vector. As shown in Fig. 2a and Table 1 , wt5-HT 2B and R393X bound LSD with similar affinity (1.99 F 0.62 nM and 2.24 F 0.30 nM, respectively) and displayed similar expression levels (B max of 1.10 F 0.02 and 1.43 F 0.09 pmol/mg proteins, respectively). Pools of transfected CHO-K1 cells expressing wt5-HT 2B -GFP or R393X-GFP were also assayed for total receptor expression by FACS analysis. As shown in Fig. 2b , both constructs were expressed at similar level. The subcellular distribution of wt5-HT 2B -GFP and R393X-GFP was also similar, as analyzed by confocal microscopy (Fig. 2c) . Both fusion proteins were detected at the plasma membrane, although a fraction of the receptor was seen intracellularly.
R393X mutant can not activate intracellular signaling
We next tested the ability of these non-clonal cell populations expressing wt5-HT 2B and R393X to trigger intracellular calcium release using the aequorin assay. As shown in Fig. 3a and Table 1 , 5-HT and BW723C86, a selective agonist for 5-HT 2B , elicit a robust increase of intracellular calcium in cells expressing wt5-HT 2B , characterized by EC 50 of 4.34 and 3.09 nM, respectively. A similar functional response to 5-HT was found in cells expressing wt5-HT 2B -GFP and wt5-HT 2B -FLAG (Fig. 3b) , whereas no response was observed in cells expressing R393X or transfected with vector only, up to 1 AM of either agonist (Fig. 3c) .
To investigate whether the absence of calcium release in R393X-expressing cells was the consequence of a higher constitutive activity of the R393X mutant and of subsequent receptor desensitization, we analyzed the IP production of COS cells transiently transfected with various constructs of wt5-HT 2B and R393X. A FLAG epitope fused to the amino- Fig. 5 . Absence of dominant negative effect of the R393X mutation on wt5-HT 2B function. (A) The effect of R393X on the cell surface expression of wt5HT2B-FLAG was determined by FACS analysis as described in Fig.  4b , using FITC-coupled anti-FLAG monoclonal antibody, 48 h after plasmid co-transfection in COS cells. The displayed histogram represents a typical experiment out of two performed independently. (B) The effect of R393X on the IP production mediated by wt5HT2B-FLAG in response to 5-HT stimulation was analyzed in COS cells 48 hours after being co-transfected with different concentration ratios of wt5HT2B-FLAG and R393X mutant. Results were expressed and normalized as presented in Fig. 4a . The displayed histogram represents a typical experiment out of two performed independently.
terminal domain of receptors was used to compare the results of functional assays with cell surface expression.
Different concentrations of the various plasmid constructs were transfected in COS cells and assayed after 48 h for IP production and FACS analysis. As shown in Fig. 4a , basal IP production was not different between the various concentrations of wt5-HT 2B , R393X, or control plasmids, demonstrating that neither wt5-HT 2B nor R393X mutant presented a constitutive activity in COS cells. By contrast, a significant increase of IP production could be seen for metabotropic glutamate receptor 1a, known to display robust constitutive activity (data not shown). Also, consistent with the results of aequorin assays, only cells expressing wt5-HT 2B but not R393X showed an increase of IP production in response to 1 AM 5-HT (Fig. 4a) despite similar percentages of GFPpositive cells (Fig. 4b) and cell surface receptor expression as detected by a monoclonal antibody against the FLAG epitope (Fig. 4c) .
R393X mutant produces no dominant negative effect
To investigate whether R393X has a dominant negative effect on wt5-HT 2B function, we co-transfected various concentrations of R393X plasmid together with FLAGwt5-HT 2B and assayed wt5HT 2B cell surface expression by FACS analysis as well as IP production. Receptor cell surface expression (Fig. 5a ) or receptor function (Fig. 5b) ruled out a dominant negative effect even following cotransfection of a 3:1 ratio of R393X-wt5-HT 2B .
Discussion
We investigated the 5-HT 2B gene in 10 patients who developed PPH after intake of fenfluramines and found a mutation in one (patient 2, Table 1 ). It truncates most of the carboxy-terminal tail of the receptor, including the C-terminal PDZ motif (Fig. 1) . This mutation is rare as it was not found in a sample of 160 control chromosomes from the same population. In spite of normal expression at the plasma membrane and of normal agonist binding (Table 1 ; Fig. 2 ), the mutation causes loss of 5-HT 2B function as measured by IP production ( Fig. 4a ; Table 1 ) and by calcium-dependent aequorin luminescence (Fig. 3c) . Although endogenous receptor expression precluded these experiments to be performed in cultures of pulmonary vascular cells, our results from COS and CHO cells clearly show that an intact C-terminal tail is necessary for IP cascade activation, and for calcium release, by 5-HT 2B . The mutated receptor displays no constitutive activity as compared with the wild-type receptor, and does not produce a dominant negative effect on the latter in co-transfection experiments (Fig. 5) . Considering the rarity of the mutation and of the phenotype, their association is unlikely to result from chance and indicates that heterozygous, i.e. partial, loss of 5-HT 2B function played a causal role in PPH disease progression at least in this patient.
Fenfluramines are transported by the 5-HT transporter (5-HTT) into the cytoplasm of 5-HTT-expressing cells, where they release 5-HT from storage vesicles [7] . 5-HT produces a globally vasoconstrictive effect on pulmonary arteries in most species studied [18 -20] . The wild-type 5-HT 2B receptor subtype, however, elicits a reversible endotheliumdependent relaxation of pulmonary arteries in pigs, associated with an increase in cyclic GMP [9] , through coupling to the nitric oxide (NO) signalling pathway [11] . The PDZ motif at the C-terminus of 5-HT 2B is required for activation of eNOS [11] . The 5-HT 2B receptor is furthermore coupled to G-protein Gq and intracellular calcium release [8] , and the calcium/calmodulin complex is thought to activate eNOS in at least some vascular beds [21] . As the R393X mutation abolishes calcium release and removes the PDZ motif, we conclude that the mutated receptor has lost its ability to stimulate eNOS. Expression of the eNOS enzyme is decreased in PPH both at mRNA and protein level to an extent that is inversely proportional to vascular resistance [22] . Therefore, maximal stimulation of eNOS by 5-HT 2B might be a limiting factor, consistent with a model where imbalances in the endothelial production of vasodilators and vasoconstrictors play a significant role in PPH disease progression [23] . Of note, the 5-HT 2B receptor is strongly overexpressed in pulmonary arteries of PPH patients [10] . We speculate that this strong overexpression is a secondary event that partially counterbalances the vasoconstrictive effect of 5-HT, and that susceptibility to fenfluramines was increased in our patient because of the heterozygous loss of function. Homozygous 5-HT 2B loss-of-function mutations are not expected in PPH patients, whose phenotype is normal at birth and in infancy, in view of the severe congenital cardiomyopathy in homozygous 5-HT 2B knockout mice [24] .
It remains uncertain which receptor subtype mediates pulmonary vasoconstriction by 5-HT. Both the 5-HT 1B and 5-HT 2A receptors are expressed in human small muscular pulmonary arteries, and both have been implicated in vasoconstriction [20, 25] . In mice chronically submitted to hypoxia, a model which shares features with PPH, 5-HT 2B was shown to be required for smooth muscle cell proliferation and structural remodeling of pulmonary arteries [10] , consistent with the ability of 5-HT 2B to initiate cell cycle progression in mouse fibroblasts [26] . In that model 5-HT 2B was furthermore required for the potentiation of PH by dexfenfluramine [10] . If this myoproliferative effect of 5-HT 2B is relevant to human smooth muscle cells from PPH patients, we hypothesize that it can be produced by one allele only, i.e. that it is not haploinsufficient, although no data are reported in heterozygous mice [10] . It is hence not excluded that the 5-HT 2B receptor, besides endotheliumdependent vasodilation, also participated in pulmonary arterial smooth muscle cells proliferation or remodeling in our patient. This hypothesis could not be tested because our patient's lungs were explanted years before the present study, and were hence not available for analysis.
A germline BMPR2 mutation can be detected in up to 30% of patients with apparently sporadic PPH [6] . No mutation of this gene was found in our five patients exposed to fenfluramines. Although BMPR2 and 5-HT 2B mutations might theoretically be associated with distinct subgroups of PPH patients, these genes are more likely part of a complex network of signalling pathways where several, non-mutually exclusive mutations may predispose to PPH. Indeed, BMPR2 mutations have been found in some patients with fenfluramine-triggered PPH [27] . Of note, these patients had a mean duration of exposure to fenfluramine of less than 3 months, while the patient in the present study reported a 9-month exposure (Table 1 ). More importantly, BMPR-II [28] and BMPR-IA [29] protein expression at the plasma membrane of pulmonary endothelial cells is decreased not only in hereditary PPH with germline BMPR2 mutations but also in non-hereditary PPH and in secondary PH cases, highlighting the essential role of the BMP/TGF-h/SMAD pathway [30] in possibly all forms of PH. Experimentally, BMPs suppress proliferation of pulmonary artery smooth muscle cells from normal controls but not from PPH patients [31] . We assume that these changes were present in our patient with the 5-HT 2B mutation, but her explanted lungs were not available for study.
A frequent polymorphism of the 5-HTT gene increases the expression of 5-HTT in pulmonary artery smooth muscle cells, and is associated with PPH, albeit not specifically with appetite-suppressant-associated PPH [32] . A search for polymorphisms in candidate serotonergic genes, followed by genetic association studies, should address whether some multigenic variability in 5-HT signalling predisposes to PPH.
